Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
McEwen Stem Cell Institute, University Health Network, Toronto, Ontario, Canada.
Nat Protoc. 2022 Dec;17(12):2721-2738. doi: 10.1038/s41596-022-00743-1. Epub 2022 Oct 12.
Despite recent advances in the differentiation of human pluripotent stem cells into multiple cell types for application in replacement therapies, tissue vascularization remains a bottleneck for regenerative medicine. Fragments of primary microvessels (MVs) harvested from adipose tissue retain endothelialized lumens and perivascular cell coverage. We have used these MVs to support the survival and engraftment of transplanted human pluripotent stem cell-derived cardiomyocytes, pancreatic progenitors or primary human islets. MVs connect with host vessels, perfuse with blood and form a hierarchal vascular network in vivo after subcutaneous or intracardiac transplantation. MVs also display the ability to remodel and form stable vascular networks with long-term retention (>3.5 months). MVs can be cultured in 3D hydrogels in vitro, where they retain vessel shape and undergo angiogenic sprouting without the need for exogenous growth factor supplementation. Therefore, MVs offer a robust vascularization strategy for regenerative medicine approaches and a platform for angiogenic studies and drug testing in vitro. Here we describe in detail the protocol for: (1) the isolation of MVs from rat epididymal fat by limited collagenase digestion, followed by size-selective sieving; (2) the incorporation of MVs into 3D collagen hydrogels; (3) the in vitro culture of MVs in 3D gels for angiogenic studies; and (4) the in vivo transplantation of 3D hydrogels containing MVs into the mouse subcutis. The isolation procedure does not require highly specific equipment and can be performed in ~3 h by researchers with experience in rodent handling and cell culture.
尽管最近在将人类多能干细胞分化为多种细胞类型以应用于替代疗法方面取得了进展,但组织血管化仍然是再生医学的一个瓶颈。从脂肪组织中收获的原代微血管 (MV) 保留了内皮化的管腔和血管周围细胞覆盖。我们已经使用这些 MV 来支持移植的人类多能干细胞衍生的心肌细胞、胰腺祖细胞或原代人胰岛的存活和植入。MV 与宿主血管连接,在皮下或心脏内移植后在体内灌注血液并形成分级血管网络。MV 还显示出重塑和形成稳定血管网络的能力,具有长期保留 (>3.5 个月)。MV 可以在体外 3D 水凝胶中培养,在那里它们保持血管形状并进行血管生成发芽,而无需外源生长因子补充。因此,MV 为再生医学方法提供了一种强大的血管化策略,也是体外血管生成研究和药物测试的平台。在这里,我们详细描述了以下方案:(1) 通过有限的胶原酶消化从大鼠附睾脂肪中分离 MV,然后进行大小选择筛;(2) 将 MV 掺入 3D 胶原水凝胶中;(3) 在 3D 凝胶中体外培养 MV 进行血管生成研究;(4) 将含有 MV 的 3D 水凝胶体内移植到小鼠皮下。该分离程序不需要高度专用的设备,并且具有啮齿动物处理和细胞培养经验的研究人员可以在大约 3 小时内完成。